Publications by authors named "Shaji K Kumar"

100Publications

Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN).

Leukemia 2020 Oct 20. Epub 2020 Oct 20.

Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-01060-wDOI Listing
October 2020

Lymphoma-like double-hit genetic abnormalities ( and ) in a case of non-secretory multiple myeloma.

Leuk Lymphoma 2020 Sep 21:1-4. Epub 2020 Sep 21.

Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1821012DOI Listing
September 2020

Enrolment of racial minorities across 15 years of multiple myeloma randomised trials; calling on researchers to become agents of change.

Lancet Haematol 2020 10 1;7(10):e704-e706. Epub 2020 Sep 1.

Division of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(20)30281-7DOI Listing
October 2020

Daratumumab-lenalidomide-dexamethasone vs standard-of-care regimens: Efficacy in transplant-ineligible untreated myeloma.

Am J Hematol 2020 12 5;95(12):1486-1494. Epub 2020 Sep 5.

Department of Haematology, Lille University Hospital, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25963DOI Listing
December 2020

Role of imaging in multiple myeloma.

Am J Hematol 2020 08 18;95(8):966-977. Epub 2020 May 18.

Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25846DOI Listing
August 2020

Cost-effectiveness of once weekly carfilzomib 70 mg/m2 plus dexamethasone in patients with relapsed and refractory multiple myeloma in the United States.

Expert Rev Hematol 2020 Jun 6;13(6):687-696. Epub 2020 Apr 6.

School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital , Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2020.1746639DOI Listing
June 2020

Daratumumab in untreated newly diagnosed multiple myeloma.

Ther Adv Hematol 2019 23;10:2040620719894871. Epub 2019 Dec 23.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719894871DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928545PMC
December 2019

Stem-cell transplantation in multiple myeloma: how far have we come?

Ther Adv Hematol 2019 14;10:2040620719888111. Epub 2019 Nov 14.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719888111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859676PMC
November 2019

Time Horizons in Cost Analyses.

JAMA 2019 08;322(6):582-583

Centre for Health Economics, University of York, York, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2019.7853DOI Listing
August 2019

Recycling therapies for myeloma: The need for prospective trials.

Authors:
Shaji K Kumar

Cancer 2019 09 15;125(17):2920-2922. Epub 2019 May 15.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32177DOI Listing
September 2019

The stepchild in myeloma treatments: is allogeneic transplantation not so bad after all?

Haematologica 2019 02;104(2):222-225

Department of Oncology/Hematology, A.O.U. Città della Salute e della Scienza di Torino, Presidio Molinette, Torino, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.206987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355504PMC
February 2019

Targeted Management Strategies in Multiple Myeloma.

Authors:
Shaji K Kumar

Cancer J 2019 Jan/Feb;25(1):59-64

From the Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000353DOI Listing
March 2020

Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing.

Blood 2019 02 26;133(7):652-659. Epub 2018 Dec 26.

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-08-825349DOI Listing
February 2019

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis.

Biol Blood Marrow Transplant 2019 03 7;25(3):e108-e111. Epub 2018 Dec 7.

Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.12.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445701PMC
March 2019

Should we measure clonal circulating plasma cells in light chain amyloidosis?

Oncotarget 2018 Nov 2;9(86):35607-35608. Epub 2018 Nov 2.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235020PMC
November 2018

Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma.

Br J Haematol 2019 02 20;184(4):536-546. Epub 2018 Nov 20.

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15679DOI Listing
February 2019

Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin.

J Clin Oncol 2019 01 15;37(2):171-173. Epub 2018 Nov 15.

Shaji K. Kumar, MD; Morie A. Gertz, MD; and Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.01398DOI Listing
January 2019

Timing of treatment of smoldering myeloma: delay until progression.

Authors:
Shaji K Kumar

Blood Adv 2018 11;2(21):3050-3053

Division of Hematology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018021238DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234369PMC
November 2018

Ixazomib for the treatment of multiple myeloma.

Expert Opin Pharmacother 2018 Dec 13;19(17):1949-1968. Epub 2018 Nov 13.

g Hematology & Medical Oncology , Winship Cancer Institute, Emory University , Atlanta , GA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14656566.2018.1
Publisher Site
http://dx.doi.org/10.1080/14656566.2018.1528229DOI Listing
December 2018